Cargando…

Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD)

BACKGROUND: Genetic factors as well as environmental factors are important in the development of NAFLD and in this study we investigated associations between polymorphisms of peroxisome proliferators-activated receptor γ coactivator 1α polymorphism (PPARGC1A) and NAFLD. AIMS: We recruited 115 patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoneda, Masato, Hotta, Kikuko, Nozaki, Yuichi, Endo, Hiroki, Uchiyama, Takashi, Mawatari, Hironori, Iida, Hiroshi, Kato, Shingo, Hosono, Kunihiro, Fujita, Koji, Yoneda, Kyoko, Takahashi, Hirokazu, Kirikoshi, Hiroyuki, Kobayashi, Noritoshi, Inamori, Masahiko, Abe, Yasunobu, Kubota, Kensuke, Saito, Satoru, Maeyama, Shiro, Wada, Koichiro, Nakajima, Atsushi
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453128/ https://www.ncbi.nlm.nih.gov/pubmed/18588668 http://dx.doi.org/10.1186/1471-230X-8-27

Ejemplares similares

Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)
por: Yoneda, Masato, et al.
Publicado: (2008)

Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett's epithelium in Japanese men
por: Akiyama, Tomoyuki, et al.
Publicado: (2008)

Macroscopic extent of gastric mucosal atrophy: increased risk factor for esophageal squamous cell carcinoma in Japan
por: Akiyama, Tomoyuki, et al.
Publicado: (2009)

Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease
por: Akiyama, Tomoyuki, et al.
Publicado: (2009)

Serum nitric oxide metabolite as a biomarker of visceral fat accumulation: Clinical significance of measurement for nitrate/nitrite
por: Fujita, Koji, et al.
Publicado: (2011)

Outcomes and factors influencing survival in cirrhotic cases with spontaneous rupture of hepatocellular carcinoma: a multicenter study
por: Kirikoshi, Hiroyuki, et al.
Publicado: (2009)

Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH
por: Iida, Hiroshi, et al.
Publicado: (2012)

Endoscopic therapy using an endoscopic variceal ligation for minute cancer of the esophagogastric junction complicated with esophageal varices: a case report
por: Akiyama, Tomoyuki, et al.
Publicado: (2010)

Change of Gastric Emptying With Chewing Gum: Evaluation Using a Continuous Real-Time (13)C Breath Test (BreathID System)
por: Sakamoto, Yasunari, et al.
Publicado: (2011)

Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD
por: Nogami, Asako, et al.
Publicado: (2022)

Soluble CD14 Levels Reflect Liver Inflammation in Patients with Nonalcoholic Steatohepatitis
por: Ogawa, Yuji, et al.
Publicado: (2013)

Penetration of the sigmoid colon to the posterior uterine wall secondary to diverticulitis: a case report
por: Akiyama, Tomoyuki, et al.
Publicado: (2009)

Chemotherapeutic Treatment of Priapism in Metastatic Rectal Cancer
por: Kitai, Y., et al.
Publicado: (2008)

Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values
por: Iida, Hiroshi, et al.
Publicado: (2009)

Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: a case report
por: Nakajima, Atsushi, et al.
Publicado: (2008)

Influence of pretreatment with H2 receptor antagonists on the cure rates of Helicobacter pylori eradication
por: Tokoro, Chikako, et al.
Publicado: (2011)

Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trial
por: Yoneda, Masato, et al.
Publicado: (2022)

Current and future pharmacological therapies for NAFLD/NASH
por: Sumida, Yoshio, et al.
Publicado: (2017)

Early Effect of Single-dose Sitagliptin Administration on Gastric Emptying: Crossover Study Using the (13)C Breath Test
por: Nonaka, Takashi, et al.
Publicado: (2013)

LDL-Migration Index (LDL-MI), an Indicator of Small Dense Low-Density Lipoprotein (sdLDL), Is Higher in Non-Alcoholic Steatohepatitis than in Non-Alcoholic Fatty Liver: A Multicenter Cross-Sectional Study
por: Imajo, Kento, et al.
Publicado: (2014)

Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma
por: Kurokawa, Suguru, et al.
Publicado: (2022)

Mosapride Accelerates the Delayed Gastric Emptying of High-Viscosity Liquids: A Crossover Study Using Continuous Real-Time (13)C Breath Test (BreathID System)
por: Sakamoto, Yasunari, et al.
Publicado: (2011)

Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease
por: Hotta, Kikuko, et al.
Publicado: (2010)

Effects of Histamine-2 Receptor Antagonists and Proton Pump Inhibitors on the Rate of Gastric Emptying: A Crossover Study Using a Continuous Real-Time (13)C Breath Test (BreathID System)
por: Nonaka, Takashi, et al.
Publicado: (2011)

Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution
por: Nozaki, Yuichi, et al.
Publicado: (2015)

Identification of differentially methylated region (DMR) networks associated with progression of nonalcoholic fatty liver disease
por: Hotta, Kikuko, et al.
Publicado: (2018)

Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population
por: Zhang, Sheng, et al.
Publicado: (2018)

Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis
por: Kessoku, Takaomi, et al.
Publicado: (2016)

Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility
por: Kato, Shingo, et al.
Publicado: (2019)

Association between PPARγ, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population
por: Chen, Boyang, et al.
Publicado: (2022)

Computational Analysis of Gly482Ser Single-Nucleotide Polymorphism in PPARGC1A Gene Associated with CAD, NAFLD, T2DM, Obesity, Hypertension, and Metabolic Diseases
por: Taghvaei, Somayye, et al.
Publicado: (2021)

Two new splice variants in porcine PPARGC1A
por: Erkens, Tim, et al.
Publicado: (2008)

A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD
por: Kawaguchi, Takumi, et al.
Publicado: (2018)

Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
por: Kobayashi, Takashi, et al.
Publicado: (2022)

Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents
por: Hasegawa, Sho, et al.
Publicado: (2021)

The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice
por: Honda, Yasushi, et al.
Publicado: (2016)

Neuroendocrine Tumor Treated with Arterial Chemoembolization Using DEB-TACE
por: Suzuki, Ko, et al.
Publicado: (2019)

Characterization of PRLR and PPARGC1A genes in buffalo (Bubalus bubalis)
por: Javed, Ruheena, et al.
Publicado: (2011)

Polymorphisms in the Promoter Region of the Chinese Bovine PPARGC1A Gene
por: Li, M. J., et al.
Publicado: (2013)

Effects of PPARG and PPARGC1A gene polymorphisms on obesity markers
por: Muntean, Carmen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vqqgtgro15picgp739ihpl2ree